skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Comparison of the effects of stimulators and inhibitors of resorption on the release of lysosomal enzymes and radioactive calcium from fetal bone in organ culture. [/sup 45/Ca, rats]

Journal Article · · Endocrinology; (United States)
OSTI ID:6503364

The release of lysosomal enzymes, collagenase, and previously incorporated /sup 45/Ca from fetal rat long bones cultured in a chemically defined medium is compared. Parathyroid hormone (PTH) and prostaglandin E/sub 2/ increased the release of ..beta..-glucuronidase, acetylglucosaminidase, and cathepsin D, but showed little effect on collagenase activity in the medium at 48 h. The dose-response relations for ..beta..-glucuronidase and /sup 45/Ca release were similar. However, the increase in lysosomal enzyme release was proportionally greater and occurred earlier than the increase in /sup 45/Ca release. PTH also caused a significant increase in total ..beta..-glucuronidase activity in bone plus medium. Several agents which stimulate /sup 45/Ca release at an optimal concentration, but not at a higher concentration, including dibutyryl cAMP, isobutylmethylxanthine, and the calcium ionophore, A23187, all increased lysosomal enzyme release at the concentration which increased /sup 45/Ca release. Three inhibitors of bone resorption (calcitonin, cortisol, and colchicine) blocked lysosomal enzyme release at the same time that /sup 45/Ca release decreased. When the bones escaped from calcitonin inhibition, both /sup 45/Ca and lysosomalenzyme release increased. While colchicine blocked both lysosomal enzymes and /sup 45/CA release, it actually increased the release of bone collagenase, and together with PTH or prostaglandin E/sub 2/ caused a large increase in free collagenase activity in the medium. These data indicate that lysosomal enzyme release is closely linked to bone resorption and suggest that lysosomal enzymes may have a primary role in initiating resorption, perhaps by acting on noncollagenous matrix or tissue components before mineral removal and collagen degradation.

Research Organization:
Univ. of Connecticut Health Center, Farmington
OSTI ID:
6503364
Journal Information:
Endocrinology; (United States), Vol. 103:6
Country of Publication:
United States
Language:
English

Similar Records

Effects of prostaglandin F2 alpha on bone formation and resorption in cultured neonatal mouse calvariae: Role of prostaglandin E2 production
Journal Article · Thu Feb 01 00:00:00 EST 1990 · Endocrinology; (USA) · OSTI ID:6503364

Inhibitory effect of auranofin (I) and chloroquine (II) on bone degradation induced by the interleukin 1-like (IL-1-like) factor released from rheumatoid synovial tissue (RAST) in vitro
Conference · Sat Mar 01 00:00:00 EST 1986 · Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) · OSTI ID:6503364

Effect of alterations in the cyclopentane ring on bone resorptive activity of prostaglandin
Journal Article · Wed Feb 01 00:00:00 EST 1989 · Prostaglandins; (United States) · OSTI ID:6503364